andreeff (40 Ergebnisse)

Hardcover. Zustand: Very Good. Very good hardcover. No DJ. Text is clean and unmarked. Covers show very minor shelf wear. Bindings tight, hinges strong. Previous owners business card applied to inside front cover.; 100% Satisfaction Guaranteed! Ships same or next business day!

Broschiert. Zustand: Gut. 182 Seiten Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Einbandkanten sind leicht bestoßen. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 410.

118 S., 8°. mit graphischen Darstellungen. Kt. Alters- und Gebrauchsspuren. Gewicht (Gramm): 500.

Broschiert. Zustand: Gut. XV, 182 S. Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.). Schnitt und Einband sind etwas staubschmutzig; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Deutsch Gewicht in Gramm: 400.

Broschur. Zustand: gut. 137 S., 21 cm, Lichtrand, gebräunt. Sprache: deu.

Zustand: gut. 29 S., 7 Abb., 24 cm, gebräunt, Rand mit Läsur. Sprache: Deutsch.

Zustand: Near Fine. NY 1986. Annals of New York Academy of Science, Vol. 468. Octavo, original printed hardcover. A few institution stamps, but no spine numbers and no pocket. Near Fine.

Booklet. Zustand: Very good. No. 33 of 66 copies. Unpaginated 14 cm booklet. White card covers tied with black thread. Tiny dent in front cover. "Vol. 2 : sdoopy returns" on cover.

VIII, 141 Seiten. 49 graphische Darstellungen und 56 Tabellen. Großoktav (24x16 cm) Orig.Karton. ** Gutes, sauberes Exemplar. Mit persönlicher Widmung des Autors J. Schumann.

Hardcover. Zustand: Very Good. Concise Manual of Hematology and Oncology This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. .

Unbekannt. Zustand: Sehr gut. 670 S. Sprache: Englisch Gewicht in Gramm: 1056.

Hardcover. Zustand: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.

Broschur (Paperback) -. - internlp039-4954 Deutsch - 34 Blatt Seiten S. 31 x 22 x 1 cm - Quart 1000g. mit deutlichen Gebrauchsspuren - deutlich berieben und bestoßen mit Randläsuren, deutlich nachgedunkelt, - mit deutlichen Gebrauchsspuren - deutlich berieben und bestoßen mit Randläsuren, deutlich nachgedunkelt, -.

Opracowanie graficzne Anna Andreeff, Zbigniew B. Kot (illustrator). @ Co-Authors / Wspolautorzy: Wybor i przeklad Daniela Tomczyk-Baszkiewicz, Maryla Wisniewska-Kacprzak; wstep i komentarz D. Tomczyk-Baszkiewicz; @ Cover design and illustrations / Projekt okladki i ilustracje: Opracowanie graficzne Anna Andreeff, Zbigniew B. Kot; @ Blurb / Notka wydawnicza: Warszawa: Ludowa Spoldzielnia Wydawnicza, 1986; @ Size of the book block / Wymiar bloku: 25 cm; @ Circulation / Naklad: 20330; @ Weight / Waga: 530; @ Pages / Strony: 206, [2]s., [8]s. tabl.; @ Thematic categories / Kategorie tematyczne: design grafika uzytkowa oprawy / okladki od 1980, ilustratorzy graficy Andreeff Anna Kot Zbigniew B., literatura basn / bajka legendy i podania, literatura obca bulgarska / , , literature fairy tale legends / , , Literatur Märchen Sagen; Obwoluta bardzo nieznacznie uszkodzona. Pozycja w ladnym stanie Oprawa wydawnicza plotno, obwoluta.

Paperback. Zustand: Brand New. spiral-bound edition. 149 pages. 9.61x6.70x0.73 inches. In Stock.

3., vollst. überarb. u. erw. Aufl. XXII, 1087 S. Ehemaliges Bibliotheksexemplar mit Stempel und Rückensignaturen. Moderate Lager und Gebrauchsspuren. Text Sauber. Guter Zustand. 9783817115563 Sprache: Deutsch Gewicht in Gramm: 980.

Paperback. Zustand: Brand New. 1st edition. 700 pages. 9.20x6.10x1.58 inches. In Stock.

Zustand: Very Good. Very Good++; Hardcover; Close to new condition; Covers are still glossy with "straight" edge-corners; Unblemished textblock edges; The endpapers and all text pages are bright and unmarked; Binding is tight with a straight spine; This book will be stored and delivered in a sturdy cardboard box with foam padding; Medium Format (8.5" - 9.75" tall); Blue, purple, and orange covers with title in white lettering; 2014, Springer-Verlag Publishing; 826 pages; "Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)," by Michael Andreeff.

Couverture souple. Zustand: bon. RO30143935: 1953. In-12. Broché. Bon état, Couv. convenable, Mors fendus, Intérieur frais. 318 pages -. . . . Classification Dewey : 840.091-XX ème siècle.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven information. Hence, it was felt that a spe ties by the introduction of intensive combi cial series of symposia should be devoted to nation regimens, therapeutic progress has 'Pharmacokinetics and Management of slowed down and the impression of stagna Relapsed and Refractory Disease' comple menting the established meetings on 'Prog tion may even have occured. In contrast, the knowledge about the biology of leu nostic Factors and Treatment Strategies' kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come 'ACUTE LEUKEMIAS - Pharmacokine from a better understanding of the pharma tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto Refractory Disease' to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration for the closing distance between countries al. These achievements need to be comple and the development of effective world mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D.

Taschenbuch. Zustand: Neu. Acute Leukemias | Pharmacokinetics and Management of Relapsed and Refractory Disease | W. Hiddemann (u. a.) | Taschenbuch | xxvi | Englisch | 1992 | Springer | EAN 9783540539490 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Couverture souple. Zustand: bon. R150046808: Octobre 1953. In-12. Broché. Bon état, Couv. légèrement passée, Dos satisfaisant, Intérieur acceptable. 318 pages. . . . Classification Dewey : 800-LITTERATURE (BELLES-LETTRES).

Zustand: New.

Gebunden. Zustand: New.

Taschenbuch. Zustand: Neu. Targeted Therapy of Acute Myeloid Leukemia | Michael Andreeff | Taschenbuch | xix | Englisch | 2016 | Springer US | EAN 9781493939893 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Neuware -This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 848 pp. Englisch.

Buch. Zustand: Neu. Neuware -This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 848 pp. Englisch.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.

Paperback. Zustand: Brand New. reprint edition. 845 pages. 9.25x6.10x1.93 inches. In Stock.